Anji Reddy Dr. K.
Dr. Reddy’s Laboratories Ltd. (Reddy's), founded in 1984 by Dr. K. Anji Reddy, has become India’s biggest pharmaceuticals company. Reddy had
worked in the publicly-owned
Indian Drugs and Pharmaceuticals Ltd. Reddy's manufactures and markets a wide
range of pharmaceuticals in India and overseas. The company more than 190
medications ready for patients to take, 60 active pharmaceutical ingredients,
for drug manufacture, diagnostic kits, critical care and biotechnology products.
Reddy’s began as a supplier to
Indian drug manufacturers, but it soon started exporting to other
less-regulated markets – that had the advantage of not spend time and money on
a manufacturing plant that that would gain approval from a drug licensing body
such as the US’s Food and Drug Administration. Much of Reddy’s early success
came in those unregulated markets, where process patents – not product patents
– are recognized. With that money in the bank, the company could reverse-
engineer patented drugs from more developed countries and sell them
royalty-free in India and Russia. By the early 1990s, the expanded scale and
profitability from these unregulated markets enabled the company to begin
focusing on getting approval from drug regulators for their formulations and
bulk drug manufacturing plants in more- developed economies. This allowed their
movement into regulated markets such as the US and Europe.
By 2007, Reddy’s had six
FDA-plants producing active pharmaceutical ingredients in India and seven FDA-inspected
and ISO 9001 (quality) and [[International Organization for Standardization|ISO
14001 (environmental management) certified plants making patient-ready
medications – five of them in India and two in the UK
Revenue $1.5 Billion (MAY2007)
Net income $216
Million (MAY2007)
Employees 7,525
Comments
Post a Comment